Acute Ischemic Coronary Syndrome (AICS)

    * Serum markers
    * GP IIB/IIIA inhibitors
    * Platelet inhibitors (ASA/Clopidogrel)
    * Nitrates
    * Anticoagulation: heparin and LMW heparin
    * Fibrinolytic therapy: tPA, rPA, TNK-tPA, SK
    * PCI versus fibrinolysis
    * Combination therapy

Low Risk Chest Pain

    * History and risk factors
    * ECG limitations
    * Serum markers
    * Provocative testing
    * Observation and chest pain units
    * Protocols and pathways

Congestive Heart Failure

    * Systolic versus diastolic dysfunction
    * Traditional agents and their roles: furosemide, nitrates, morphine
    * Newer agents: ACEI, ARB
    * Vasodilators and Inotropes
    * BNP: the test and the therapy
    * Role of echo
    * Protocols and pathways

Dysrhythmias

    * Atrial fibrillation
    * Atrial flutter
    * Accessory pathways
    * MAT, EAT
    * Protocols and pathways

Implantable Devices

    * Pacemakers
    * AICD
    * LVAD

Intravascular Clotting: DVT and PTE

    * D-dimer
    * Pre-test probabilities: PIOPED
    * Diagnosis: CT vs. US vs. nuclear scan
    * Therapy: heparin vs. LMWH vs. fibrinolysis
    * Disposition: hospital vs. OBS vs. home
    * Problems with anti-coagulation
    * Protocols and pathways

Shock and Resuscitation

    * Cardiogenic Shock
    * Fulminant pulmonary edema
    * Massive PTE

Catastrophic Cardiovascular Conditions

    * Aortic dissection
    * Ruptured aortic aneurysm
    * Pericardial tamponade

Stroke and TIA

    * Acute occlusive stroke
    * TIA
    * Acute SAH

Resuscitation

    * CPR: best methods
    * Defibrillation and Cardioversion
    * External Pacing


https://wam-heart.treefrog.ephibian.net/